IMMUNOTOXICITY OF DERMAL PERMETHRIN & CIS UROCANIC ACID

皮肤氯菊酯的免疫毒性

基本信息

项目摘要

DESCRIPTION Inhibited immune responses have been observed following occupational, inadvertent, or therapeutic exposure to xenobiotics. Further, aberrant immune responses (e.g., hypersensitivity, autoimmunity) appear to be increasing in humans, a phenomenon which may be related to environmental chemical exposure. New research initiatives are determining that such exposures, often previously considered to be innocuous, may in fact be contributing to impaired human immune health. The present proposal considers immunotoxicity resulting from combined dermal exposure to a common pyrethroid insecticide (permethrin) and to cis-urcanic acid (cUCA, an isomerization product of trans-UCA and sunlight). Preliminary data have been generated showing both systemic and regional immunotoxicity from low-level topical permethrin (formerly not considered an immunotoxicant). It has previously been demonstrated that cUCA also inhibits skin and immune responses. The proposed studies will estimate the risk of immunotoxicity from combined topical permethrin and intradermal cUCA exposure, using National Toxicology Program-approved testing procedures in C57B1/6 inbred mice. These immunotoxicants will also be co-administered at levels determined to inhibit immune responses in mice, to investigate cytokine-dependent mechanisms by which cUCA and/or permethrin may cause suppression of immunity. Further, in that: 1) cUCA has been shown to inhibit antigen presentation by macrophages, 2) new data suggest the epidermal antien presenting cell (APC, Langerhans cell [LC]) may be a target of cUCA, and 3) permethrin was shown by us to inhibit skin contact hypersensitivity responses, the effect of single and combined exposure to these agents on antigen presentation by LC will be examined as a mechanism related to immunotoxicity. Providing new data to assist the estimation of risk from the combined immunotoxicant exposure (cUCA and topical insecticide) in children is a primary goal of the proposal.
描述 在职业性, 无意或治疗性接触外源性物质。 此外,异常 免疫应答(例如,超敏反应、自身免疫)似乎是 在人类中增加,这一现象可能与环境有关 化学暴露 新的研究计划正在确定, 暴露,以前通常被认为是无害的,实际上可能是 导致人体免疫健康受损。 现时的建议 认为皮肤接触常见的 拟除虫菊酯杀虫剂(氯菊酯)和顺式-urcanic酸(cUCA, 反式-UCA和阳光异构化产物)。 初步数据 显示全身和局部免疫毒性, 低水平的局部二氯苯醚菊酯(以前不被认为是免疫毒素)。 先前已经证明,cUCA还抑制皮肤和免疫系统。 应答 拟议的研究将估计免疫毒性的风险 联合局部氯菊酯和皮内cUCA暴露,使用 国家毒理学计划批准的C57 B1/6近交系动物检测程序 小鼠 这些免疫毒素也将以 确定抑制小鼠的免疫反应,以研究 cUCA和/或氯菊酯可能导致的尼古丁依赖性机制 抑制免疫力。 此外,因为:1)cUCA已被证明 抑制巨噬细胞的抗原呈递,2)新的数据表明, 表皮抗原呈递细胞(APC,Langerhans细胞[LC])可能是一个靶点 氯菊酯对皮肤接触有抑制作用 超敏反应,单次和联合暴露的影响, 这些药物对LC抗原递呈的作用将作为一种机制进行研究 与免疫毒性有关。 提供新的数据,以协助估计 联合免疫毒物暴露(cUCA和局部)的风险 杀虫剂)是该提案的主要目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven D Holladay其他文献

Steven D Holladay的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven D Holladay', 18)}}的其他基金

IMMUNOTOXICITY OF DERMAL PERMETHRIN & CIS UROCANIC ACID
皮肤氯菊酯的免疫毒性
  • 批准号:
    2729059
  • 财政年份:
    1998
  • 资助金额:
    $ 19.24万
  • 项目类别:
FISH IN IMMUNOTOXICITY RISK ASSESSMENT
鱼类免疫毒性风险评估
  • 批准号:
    2157053
  • 财政年份:
    1995
  • 资助金额:
    $ 19.24万
  • 项目类别:
FISH IN IMMUNOTOXICITY RISK ASSESSMENT
鱼类免疫毒性风险评估
  • 批准号:
    2459010
  • 财政年份:
    1995
  • 资助金额:
    $ 19.24万
  • 项目类别:
FISH IN IMMUNOTOXICITY RISK ASSESSMENT
鱼类免疫毒性风险评估
  • 批准号:
    2157054
  • 财政年份:
    1995
  • 资助金额:
    $ 19.24万
  • 项目类别:

相似海外基金

Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer
癌症中 CD8 T 细胞耗竭的抗原呈递细胞控制
  • 批准号:
    10659843
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
Regulation of Antitumor T-cell repertoire responses by antigen presenting cell subsets
抗原呈递细胞亚群调节抗肿瘤 T 细胞库反应
  • 批准号:
    23H02706
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a novel artificial antigen presenting cell to study human CD8 T cell biology
开发新型人工抗原呈递细胞来研究人类 CD8 T 细胞生物学
  • 批准号:
    574458-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 19.24万
  • 项目类别:
    University Undergraduate Student Research Awards
Development of a novel artificial antigen presenting cell to study human CD8 T cell biology
开发新型人工抗原呈递细胞来研究人类 CD8 T 细胞生物学
  • 批准号:
    564338-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 19.24万
  • 项目类别:
    University Undergraduate Student Research Awards
Molecular mechanisms on antigen presenting cell function and generation
抗原呈递细胞功能和生成的分子机制
  • 批准号:
    20H03505
  • 财政年份:
    2020
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Preserving T cell / antigen presenting cell interactions via shared L-arginine
通过共享 L-精氨酸保留 T 细胞/抗原呈递细胞相互作用
  • 批准号:
    10240447
  • 财政年份:
    2020
  • 资助金额:
    $ 19.24万
  • 项目类别:
Lung Megakaryocytes Are A Novel Professional Antigen Presenting Cell
肺巨核细胞是一种新型专业抗原呈递细胞
  • 批准号:
    9759173
  • 财政年份:
    2019
  • 资助金额:
    $ 19.24万
  • 项目类别:
Antigen presenting cell mediated regulation of intestinal inflammation
抗原呈递细胞介导的肠道炎症调节
  • 批准号:
    18K15128
  • 财政年份:
    2018
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Epithelial cell-antigen presenting cell crosstalk in the maintenance of immune homeostasis in the lung
上皮细胞-抗原呈递细胞串扰维持肺免疫稳态
  • 批准号:
    1640539
  • 财政年份:
    2015
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Studentship
The role of GCN2-kinase in antigen presenting cell function and tolerance to self
GCN2激酶在抗原呈递细胞功能和自身耐受性中的作用
  • 批准号:
    8662697
  • 财政年份:
    2013
  • 资助金额:
    $ 19.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了